“Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine”, Drugs Ther Studies, vol. 2, no. 1, p. e1, Dec. 2011, doi: 10.4081/dts.2012.e1.